Andrew M Jackson
Andrew M Jackson
Nottingham University, Duke University, Leeds University, Edinburgh University, Kennedy Institute
Dirección de correo verificada de - Página principal
Citado por
Citado por
Inhibitory effect of TNFα antibodies on synovial cell interleukin-1 production in rheumatoid arthritis
FM Brennan, A Jackson, D Chantry, R Maini, M Feldmann
The Lancet 334 (8657), 244-247, 1989
BCG immunotherapy of bladder cancer: 20 years on
AB Alexandroff, AM Jackson, MA O'Donnell, K James
The Lancet 353 (9165), 1689-1694, 1999
IL-17 expression by breast-cancer-associated macrophages: IL-17 promotes invasiveness of breast cancer cell lines
XW Zhu, LA Mulcahy, RAA Mohammed, AHS Lee, HA Franks, L Kilpatrick, ...
Breast Cancer Research 10 (6), R95, 2008
Changes in urinary cytokines and soluble intercellular adhesion molecule‐1 (ICAM‐1) in bladder cancer patients after Bacillus Calmette—Guérin (BCG) immunotherapy
AM Jackson, AB Alexandroff, RW Kelly, A Skibinska, K Esuvaranathan, ...
Clinical & Experimental Immunology 99 (3), 369-375, 1995
Cytokine production in culture by cells isolated from the synovial membrane
FM Brennan, D Chantry, AM Jackson, RN Mainif, M Feldmann
T–Cell Activation in Health and Disease, 177-186, 1989
Expression of Interleukin-18, a Th1 Cytokine, in Human Gastric Mucosa Is Increased in Helicobacter pylori Infection
T Tomita, AM Jackson, N Hida, M Hayat, MF Dixon, T Shimoyama, ...
The Journal of infectious diseases 183 (4), 620-627, 2001
Role for CD40–CD40 ligand interactions in the immune response to solid tumours
AB Alexandroff, AM Jackson, T Paterson, JL Haley, JA Ross, DL Longo, ...
Molecular immunology 37 (9), 515-526, 2000
T cells expressing γδ chain receptors in rheumatoid arthritis
FM Brennan, M Londei, AM Jackson, T Hercend, MB Brenner, RN Maini, ...
Journal of autoimmunity 1 (4), 319-326, 1988
Mechanisms of action of intravesical bacille Calmette-Guerin: local immune mechanisms
S Prescott, AM Jackson, SJ Hawkyard, AB Alexandroff, K James
Clinical infectious diseases 31 (Supplement_3), S91-S93, 2000
Interleukin-6 production by bladder tumors is upregulated by BCG immunotherapy
K Esuvaranathan, AB Alexandroff, M McIntyre, AM Jackson, S Prescott, ...
The Journal of urology 154 (2), 572-575, 1995
Recent advances in bacillus Calmette–Guerin immunotherapy in bladder cancer
AB Alexandroff, S Nicholson, PM Patel, AM Jackson
Immunotherapy 2 (4), 551-560, 2010
A recombinant E. coli vaccine to promote MHC class I-dependent antigen presentation: application to cancer immunotherapy
KJ Radford, DE Higgins, S Pasquini, EJ Cheadle, L Carta, AM Jackson, ...
Gene therapy 9 (21), 1455-1463, 2002
Prognosis of intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer by immunological urinary measurements: statistically weighted syndromes analysis
AM Jackson, AV Ivshina, O Senko, A Kuznetsova, A Sundan, ...
The Journal of urology 159 (3), 1054-1063, 1998
Cytokine‐modified Mycobacterium smegmatis as a novel anticancer immunotherapy
SL Young, M Murphy, XW Zhu, P Harnden, MA O'Donnell, K James, ...
International journal of cancer 112 (4), 653-660, 2004
Bugs as drugs for cancer
EJ Cheadle, AM Jackson
Immunology 107 (1), 10, 2002
Induction of ICAM 1 expression on bladder tumours by BCG immunotherapy.
AM Jackson, AB Alexandroff, M McIntyre, K Esuvaranathan, K James, ...
Journal of clinical pathology 47 (4), 309-312, 1994
Human dendritic cells genetically engineered to express a melanoma polyepitope DNA vaccine induce multiple cytotoxic T-cell responses
SG Smith, PM Patel, J Porte, PJ Selby, AM Jackson
Clinical cancer research 7 (12), 4253-4261, 2001
The Effects of Recombinant Human Intereron-Gamma on a Panel of Human Bladder Cancer Cell Lines
S Hawkyard, K James, S Prescott, AM Jackson, AWS Ritchie, JF Smyth, ...
The Journal of urology 145 (5), 1078-1081, 1991
The inhibitory effects of interferon gamma on the growth of bladder cancer cells
SJ Hawkyard, AM Jackson, K James, S Prescott, JF Smyth, GD Chisholm
The Journal of urology 147 (5), 1399-1403, 1992
Mycobacterium bovis bacillus Calmette–Guérin‐infected dendritic cells potently activate autologous T cells via a B7 and interleukin‐12‐dependent mechanism
EJ Cheadle, PJ Selby, AM Jackson
Immunology 108 (1), 79-88, 2003
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20